Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00392795 · ClinicalTrials.gov registry record

The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors

A clinical trial of Dementia and Delirium, sponsored by Vanderbilt University Medical Center.

Active
Registry status
826
Enrollment target
2
Study locations

NCT00392795: Active study of Dementia and Delirium, sponsored by Vanderbilt University Medical Center.

NCT00392795 is a study of Dementia and Delirium that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 826 participants, below the 7,719-participant average among 199 other Dementia trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00392795, a study of Dementia and Delirium, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
826 participants
Enrollment target
2
Study locations

Study Summary

The primary purpose of this proposal will be to identify potentially modifiable risk factors of long-term cognitive impairment (i.e. development of delirium and exposure to sedative and analgesic medications) in ICU patients. The investigators will quantify the independent contribution of these risk factors to the incidence of long-term cognitive impairment, controlling for other established risk factors including age, pre-existing cognitive impairment, and apolipoprotein E (apoE) genotype. Quantifying the contributions of these modifiable risk factors will pave the way for the development of preventive and/or treatment strategies to reduce the incidence, severity and/or duration of long-term cognitive impairment and improve functional recovery for patients with critical illness.

Study Locations (2)

Tennessee

  • Saint Thomas Hospital - Nashville
  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 826 participants
Start Date 2007-01
Est. Completion 2026-12

What the registry record for NCT00392795 still lists

NCT00392795 is an observational study that tracks outcomes without assigning an intervention. The registered 826 participants enrollment target is mid-sized for trials with a published cap, below the 7,719-participant average among 199 other Dementia trials with a reported enrollment target (89% lower).

The record links to 3 conditions, with Dementia appearing as the primary indexed condition, and to 0 interventions.

NCT00392795 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT00392795 about?

NCT00392795 is a clinical study titled "The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors". The primary purpose of this proposal will be to identify potentially modifiable risk factors of long-term cognitive impairment (i.e. development of delirium and exposure to sedative and analgesic medications) in ICU patients. The investigators will quantify the independent contribution of these risk...

What is the current status of trial NCT00392795?

This trial is currently active not recruiting. The enrollment target is 826 participants. The study started on 2007-01. Estimated completion is 2026-12.

What conditions does trial NCT00392795 study?

This clinical trial studies the following conditions: Dementia, Delirium, Cognition Disorders.

Who is sponsoring clinical trial NCT00392795?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00392795 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00392795's enrollment target sits among peer trials

826 36th of 199 higher than 164 of 199 other Dementia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03547973 · 827 participants · Phase 2

    Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

  • NCT05630482 · 825 participants · NA

    Randomized Trial of Healthy Family Foundations

  • NCT06097728 · 825 participants · Phase 3

    MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

  • NCT07102641 · 825 participants · Phase 4

    Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00392795, the US trial registry maintained by the National Library of Medicine. NCT00392795 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.